Evoke Pharma Inc (NASDAQ:EVOK) currently has a daily average trading volume of 15.70K but it saw 139777399 shares traded in last market. With a market cap of 10.43M USD, the company’s current market price of $6.99 came rising about 162.78 while comparing to the previous closing price of $2.66. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.32 and as low as $1.94. In the recent trading on the day, stock has struck highest price mark of $6.15 while lowest mark touched by it was $9.88.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which upgraded the stock as “Buy” in its note to investors issued on June 22, 2020, recommending a price target of $10 for it. B. Riley FBR Inc. issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $10 and $5.
Over the week, EVOK’s stock price is moving 162.78% up while it is 136.95% when we observe its performance for the past one month. Year-to-date it is 7.87% up and over the past year, the stock is showing an upside performance of 58.14%.
Currently, Evoke Pharma Inc’s total number of outstanding shares is 1.49M with 1.34% of that held by the insiders while 16.23% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -85.72% and return on equity (ROE) at -108.77%. It has a 4.69 of forward P/E ratio. Stock’s beta reads -0.08. Stock has a price to book (P/B) ratio of 1.79 while price to sale or P/S ratio amounts to 0.90. Its return on asset (ROA) is -35.23% on average.
